EPIC1

Chr 22

epigenetically induced MYC interacting lncRNA 1

Also known as: Lnc-EPIC1

0
ClinVar variants
0
Pathogenic / LP
pLI score
8
Active trials
Clinical SummaryEPIC1
💊
Clinical Trials
8 active or recruiting trials — potential therapeutic options may be available
Some data sources returned errors (1)

clinvarCount: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

EPIC1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype

No OMIM entries found.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Prostate Adenocarcinoma

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

RECRUITING
NCT05050084Phase PHASE3NRG OncologyStarted 2021-12-06
BicalutamideBuserelinDarolutamide
Prostate Cancer

Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)

ACTIVE NOT RECRUITING
NCT03999151Phase NAUniversity of California, San FranciscoStarted 2018-05-11
Exercise and Diet
Prostate CancerRadiotherapy Side Effect

Prostate Reirradiation Toxicity Outcomes Feasibility Study

NOT YET RECRUITING
NCT05614700Phase NAUniversity of LeedsStarted 2022-11-15
BrachytherapySterotactic Body Radiotherapy
Stage II Prostate Adenocarcinoma AJCC v7

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

ACTIVE NOT RECRUITING
NCT03367702Phase PHASE3NRG OncologyStarted 2018-02-01
Intensity-Modulated Radiation TherapyQuality-of-Life AssessmentQuestionnaire Administration
Prostate AdenocarcinomaStage III Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

ACTIVE NOT RECRUITING
NCT04513717Phase PHASE3NRG OncologyStarted 2021-01-21
ApalutamideBicalutamideBiospecimen Collection
Prostate Cancer

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

ACTIVE NOT RECRUITING
NCT01368588Phase PHASE3Radiation Therapy Oncology GroupStarted 2011-07
radiation therapyWhole-pelvic radiotherapy (WPRT)
Prostate Cancer

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

ACTIVE NOT RECRUITING
NCT04404894Myriad Genetic Laboratories, Inc.Started 2020-04-30
Prostate Cancer

Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

RECRUITING
NCT04396808Phase NAUniversity of Michigan Rogel Cancer CenterStarted 2020-11-05
DecipherProlarisOncotype Dx Genomic Prostate Score (GPS)